Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cumberland Pharmaceuticals (CPIX) Return on Capital Employed (2016 - 2026)

Cumberland Pharmaceuticals' Return on Capital Employed history spans 15 years, with the latest figure at 8.07% for Q4 2025.

  • On a quarterly basis, Return on Capital Employed rose 638.0% to 8.07% in Q4 2025 year-over-year; TTM through Dec 2025 was 8.07%, a 638.0% increase, with the full-year FY2025 number at 7.08%, up 659.0% from a year prior.
  • Return on Capital Employed hit 8.07% in Q4 2025 for Cumberland Pharmaceuticals, down from 7.66% in the prior quarter.
  • Over the last five years, Return on Capital Employed for CPIX hit a ceiling of 6.51% in Q2 2021 and a floor of 23.14% in Q3 2024.
  • Historically, Return on Capital Employed has averaged 11.25% across 5 years, with a median of 9.15% in 2023.
  • Biggest five-year swings in Return on Capital Employed: crashed -1391bps in 2024 and later soared 1548bps in 2025.
  • Tracing CPIX's Return on Capital Employed over 5 years: stood at 11.5% in 2021, then increased by 22bps to 9.02% in 2022, then crashed by -87bps to 16.83% in 2023, then increased by 14bps to 14.44% in 2024, then skyrocketed by 44bps to 8.07% in 2025.
  • Business Quant data shows Return on Capital Employed for CPIX at 8.07% in Q4 2025, 7.66% in Q3 2025, and 6.66% in Q2 2025.